...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and in vitro anticancer evaluation of some novel hexahydroquinoline derivatives having a benzenesulfonamide moiety.
【24h】

Synthesis and in vitro anticancer evaluation of some novel hexahydroquinoline derivatives having a benzenesulfonamide moiety.

机译:一些具有苯磺酰胺部分的新型六氢喹啉衍生物的合成和体外抗癌评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Inhibition of carbonic anhydrase isozymes has been found to have a role in the treatment of cancer. Several sulfonamide compounds bearing an aromatic or a heteroaromatic ring were found to posses potent carbonic anhydrase inhibitory activity and so can be used in the treatment of several types of cancer. In this paper, we present the synthesis of some novel quinoline 7-13, 21-26, 28 and pyrimidoquinoline 14-18, 20, 27 derivatives having a sulfonamide moiety. All the newly synthesized compounds were evaluated for their in vitro anticancer activity. Several compounds showed interesting cytotoxic activities when compared with the used reference drug. In addition, docking of the synthesized compounds into carbonic anhydrase isozyme II (CA II) active site was performed in order to give a suggestion about the proposed mechanism of action.
机译:已经发现碳酸酐酶同工酶的抑制在癌症的治疗中起作用。已发现几种带有芳族或杂芳族环的磺酰胺化合物具有有效的碳酸酐酶抑制活性,因此可用于治疗多种类型的癌症。在本文中,我们介绍了一些具有磺酰胺部分的新型喹啉7-13、21-26、28和嘧啶喹啉14-18、20、27衍生物的合成。评价所有新合成的化合物的体外抗癌活性。与使用的参考药物相比,几种化合物表现出令人感兴趣的细胞毒性活性。另外,进行合成化合物对接至碳酸酐酶同工酶II(CA II)活性位点,以便对所提出的作用机理提出建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号